Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion Positive Prostate Cancer
PubMed Full text in PMC Similar studies Analyze with GEO2R
AR and c-Myb depletion effects in prostate cancer cells
Genome-wide analysis of c-Myb-responsive gene expression in prostate cancer cells
Genome-wide analysis of AR-responsive gene expression in prostate cancer cells
Selective Targeting of PARP2 Inhibits Androgen Receptor Signaling and Prostate Cancer Growth Through Disruption of FOXA1 Function
PubMed Full text in PMC Similar studies
Genome-wide occupation of AR, FOXA1, and H3K27AC in LNCaP cells treated with selective PARP2 inhibitor UPF-1069
PubMed Full text in PMC Similar studies SRA Run Selector
Gene expression profilings for prostate cancer cells after inhibition of PARP1 or PARP2 using pharmaceutical or siRNA-based approaches
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Dtx3L and Androgen Signaling in Prostate Cancer
Genomic Analysis of DNA Repair Genes and Androgen Signaling in Prostate Cancer
Targeting the EWS/ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
ERG deregulation induces PIM-1 over-expression and aneuploidy in prostate epitheilial cells
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer (expression)
Development of peptidomimetic inhibitors of the ERG transcription factor in prostate cancer (ChIP-seq)
Effect of PARP1 inhibition on transcription high and low PARP activity cell lines
Effect of PARP1 inhibition on transcription in MCF7 cells
Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer
Chromothripsis drives DNA amplification in cancer cells developing drug resistance
Expression data of TAGLN-overexpressing RKO human colon cancer cells
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on